Education moderates the association between motor involvement and executive status in ALS
- PMID: 39739450
- PMCID: PMC11683459
- DOI: 10.1111/ene.70027
Education moderates the association between motor involvement and executive status in ALS
Abstract
Background: This study aimed to determine whether educational attainment-a common proxy of cognitive reserve (CR)-influences the association between motor and cognitive/behavioural outcomes in a large cohort of ALS patients without dementia.
Methods: N = 726 ALS patients without FTD were assessed for motor (ALSFRS-R), cognitive (Edinburgh Cognitive and Behavioural ALS Screen, ECAS) and behavioural outcomes (ECAS-Carer Interview, ECAS-CI). CR was operationalized via educational attainment (in years). Moderation models were run on each subscale of the cognitive section of the ECAS and on the ECAS-CI by addressing ALSFRS-R as the predictor and education as the moderator.
Results: Education was associated with both the ALSFRS-R and all the cognitive subscales of the ECAS, while not with the ECAS-CI. As to moderation models, a significant Education*ALSFRS-R interaction was detected solely with regard to the ECAS-Executive-with its simple slope-based decomposition revealing that higher ALSFRS-R scores were associated with higher scores on the ECAS-Executive for patients with low (p < 0.001) and average (p = 0.007), while not high, levels of education.
Discussion: Education seems to moderate the association between motor involvement and executive status in ALS patients without dementia, thus possibly exerting a protective role towards both motor function and cognition in this population.
Keywords: amyotrophic lateral sclerosis; cognitive reserve; disease severity; executive functions; frontotemporal degeneration.
© 2024 The Author(s). European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
Conflict of interest statement
V. S. received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l. and Novartis Pharma AG, receives or has received research support from the Italian Ministry of Health, AriSLA and E‐Rare Joint Transnational Call. He is in the Editorial Board of
Figures
References
-
- Abrahams S. Neuropsychological impairment in amyotrophic lateral sclerosis–frontotemporal spectrum disorder. Nat Rev Neurol. 2023;19:655‐667. - PubMed
-
- Elamin M, Bede P, Byrne S, et al. Cognitive changes predict functional decline in ALS: a population‐based longitudinal study. Neurology. 2013;80:1590‐1597. - PubMed
-
- Consonni M, Dalla Bella E, Bersano E, Telesca A, Lauria G. Cognitive reserve is associated with altered clinical expression in amyotrophic lateral sclerosis. Amyotroph Lateral Scler and Frontotemporal Degener. 2021;22(3–4):237‐247. - PubMed
-
- Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS‐R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169:13‐21. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
